232 related articles for article (PubMed ID: 17404481)
1. [Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis].
Sugiyama E
Clin Calcium; 2007 Apr; 17(4):528-34. PubMed ID: 17404481
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of serum matrix metalloproteinase-3(MMP-3) level in the diagnosis of rheumatoid arthritis].
Yamanaka H
Nihon Rinsho; 2002 Dec; 60(12):2325-30. PubMed ID: 12510357
[TBL] [Abstract][Full Text] [Related]
3. [Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis].
Shingu M; Obata K; Ezaki I; Tomari K; Fujikawa Y; Wada T; Nonaka S; Suenaga Y; Iwata K; Nobunaga M
Ryumachi; 1995 Feb; 35(1):15-24. PubMed ID: 7732485
[TBL] [Abstract][Full Text] [Related]
4. Bone and joint destruction in rheumatoid arthritis: what is really happening?
Goldring SR
J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
[TBL] [Abstract][Full Text] [Related]
5. Osteoclasts are essential for TNF-alpha-mediated joint destruction.
Redlich K; Hayer S; Ricci R; David JP; Tohidast-Akrad M; Kollias G; Steiner G; Smolen JS; Wagner EF; Schett G
J Clin Invest; 2002 Nov; 110(10):1419-27. PubMed ID: 12438440
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis?
Dayer JM
J Rheumatol Suppl; 2002 Sep; 65():10-5. PubMed ID: 12236616
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of joint destruction in rheumatoid arthritis.
Cunnane G; Hummel KM; Muller-Ladner U; Gay RE; Gay S
Arch Immunol Ther Exp (Warsz); 1998; 46(1):1-7. PubMed ID: 9510939
[TBL] [Abstract][Full Text] [Related]
8. [Stromelysin-1 in inflammatory disease: significance, specificity, and regulation elements].
Ribbens C; Malaise M
Bull Mem Acad R Med Belg; 2001; 156(5-6):275-81; discussion 281-3. PubMed ID: 11928230
[TBL] [Abstract][Full Text] [Related]
9. The role of cytokines in the pathogenesis of rheumatoid arthritis.
Feldmann M; Maini RN
Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():3-7. PubMed ID: 10646481
[TBL] [Abstract][Full Text] [Related]
10. [Cytokines in rheumatoid arthritis: new therapeutic possibilities].
Szekanecz Z; Szegedi G
Orv Hetil; 1998 Apr; 139(14):819-23. PubMed ID: 9569729
[TBL] [Abstract][Full Text] [Related]
11. [The role of cytokines and growth factors in rheumatoid joint destruction].
Alsalameh S; Kalden JR; Burmester GR
Z Rheumatol; 1991; 50(6):347-59. PubMed ID: 1796655
[TBL] [Abstract][Full Text] [Related]
12. Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis.
Kaneko M; Tomita T; Nakase T; Ohsawa Y; Seki H; Takeuchi E; Takano H; Shi K; Takahi K; Kominami E; Uchiyama Y; Yoshikawa H; Ochi T
Rheumatology (Oxford); 2001 Mar; 40(3):247-55. PubMed ID: 11285370
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I.
van den Berg WB; Bresnihan B
Baillieres Best Pract Res Clin Rheumatol; 1999 Dec; 13(4):577-97. PubMed ID: 10652641
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease.
Delgado M; Abad C; Martinez C; Leceta J; Gomariz RP
Nat Med; 2001 May; 7(5):563-8. PubMed ID: 11329057
[TBL] [Abstract][Full Text] [Related]
15. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis.
Yamanaka H; Matsuda Y; Tanaka M; Sendo W; Nakajima H; Taniguchi A; Kamatani N
Arthritis Rheum; 2000 Apr; 43(4):852-8. PubMed ID: 10765930
[TBL] [Abstract][Full Text] [Related]
16. [Increased levels of circulating hyaluronate in the sera of patients with rheumatoid arthritis with special reference to joint destruction].
Yamada N; Uzuki M; Rikimaru A; Sakurai M; Sawai T
Ryumachi; 1994 Aug; 34(4):752-60. PubMed ID: 7974026
[TBL] [Abstract][Full Text] [Related]
17. [Role of cytokines and growth factors in joint destruction processes].
Alsalameh S; Jerez R; Bujía J; Haeupl T; Kalden JR; Burmester GR
Rev Med Chil; 1992 Dec; 120(12):1400-10. PubMed ID: 1343382
[TBL] [Abstract][Full Text] [Related]
18. Cytokine production in the rheumatoid joint: implications for treatment.
Feldmann M; Brennan FM; Chantry D; Haworth C; Turner M; Abney E; Buchan G; Barrett K; Barkley D; Chu A
Ann Rheum Dis; 1990 Jun; 49 Suppl 1():480-6. PubMed ID: 2197999
[TBL] [Abstract][Full Text] [Related]
19. Serum matrix metalloproteinase 3 as a predictor of joint destruction in rheumatoid arthritis: comment on the article by Yamanaka et al.
Mattey DL; Dawes PT; Cheung NT
Arthritis Rheum; 2000 Nov; 43(11):2614-5. PubMed ID: 11083293
[No Abstract] [Full Text] [Related]
20. [Cytokines and chemical mediators in rheumatoid arthritis].
Miyasaka N
Nihon Rinsho; 1992 Mar; 50(3):463-7. PubMed ID: 1588732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
